ArticleScientific reports2025
Impact of hypertension on changes in peripapillary retinal nerve fiber layer thickness in type 2 diabetes patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To determine longitudinal changes in the peripapillary retinal nerve fiber layer (pRNFL) thickness in type 2 diabetes mellitus (T2DM) patients with hypertension (HTN). Participants were divided into three groups: normal controls (Group 1), patients with T2DM (Group 2), and patients with both T2DM and HTN (Group 3). Following the initial examination, patients underwent three additional examinations at 1-year intervals. Linear mixed models were used to identify significant changes in pRNFL thickness over time. The baseline mean pRNFL thickness was 95.4 ± 7.9, 93.6 ± 7.8, and 90.7 ± 10.1 μm in Group 1, Group 2, and Group 3, respectively, (P = 0.046). The reduction rate for mean pRNFL thickness was - 0.15 μm/y in Group 1, - 0.54 μm/y in Group 2, and - 1.06 μm/y in Group 3, respectively (P = 0.026). In Group 2, T2DM duration (estimate = - 0.63, P = 0.002) was a significant factor associated with changes in pRNFL thickness in multivariate analysis. In Group 3, HTN duration (estimate = - 0.59, P = 0.036) and HbA1c levels (estimate = - 4.44, P = 0.019) were significantly associated with pRNFL changes. Under ischemic conditions caused by HTN, pRNFL damage due to diabetic retinal neurodegeneration is considered to be more severe. In such patients, the duration of ischemic damage caused by HTN appears to have a significant impact on pRNFL damage, and stricter blood glucose level control could help reduce pRNFL damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.